Holen Sie sich die Stockscreener-App
123.85
3.85%
4.59
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$119.26
Offen:
$119.26
24-Stunden-Volumen:
2.37M
Relative Volume:
1.38
Marktkapitalisierung:
$18.92B
Einnahmen:
$4.28B
Nettoeinkommen (Verlust:
$1.26B
KGV:
15.69
EPS:
7.8957
Netto-Cashflow:
$943.00M
1W Leistung:
+2.64%
1M Leistung:
+25.15%
6M Leistung:
+56.04%
1J Leistung:
-9.59%
1-Tages-Spanne:
$118.97
$125.41
1-Wochen-Bereich:
$117.50
$126.94
52-Wochen-Spanne:
$68.70
$153.06
Illumina Inc Stock (ILMN) Company Profile
Firmenname
Illumina Inc
Sektor
Branche
Telefon
(858) 202-4500
Adresse
5200 ILLUMINA WAY, SAN DIEGO, CA
Vergleichen Sie ILMN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
123.85 | 18.22B | 4.28B | 1.26B | 943.00M | 7.8957 |
|
TMO
Thermo Fisher Scientific Inc
|
587.48 | 215.18B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.39 | 156.94B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
725.91 | 55.05B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
151.25 | 41.12B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
224.90 | 36.97B | 15.90B | 1.28B | 2.21B | 7.2842 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Bestätigt | Citigroup | Neutral |
| 2025-02-28 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-02-10 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-11-12 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-08-28 | Hochstufung | Argus | Hold → Buy |
| 2024-08-16 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-01-04 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-11-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Eingeleitet | Bernstein | Underperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Neutral |
| 2023-01-25 | Herabstufung | Argus | Buy → Hold |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Perform |
| 2022-12-12 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-04 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Hochstufung | Stifel | Hold → Buy |
| 2022-01-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Underweight |
| 2020-12-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-10-13 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2020-09-21 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-24 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-10-25 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Illumina Inc Aktie (ILMN) Neueste Nachrichten
The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know - TradingView
Will Illumina Inc. (ILU) stock keep high P E multiplesWeekly Market Report & Daily Chart Pattern Signal Reports - newser.com
Genomic Biomarker Market By Top Companies Illumina,Thermo - openPR.com
Is Illumina Inc. (ILU) stock positioned for digital growth eraSwing Trade & Daily Price Action Insights - newser.com
Is Illumina Inc. forming a bottoming baseRate Cut & Real-Time Volume Analysis - newser.com
Committed to accelerating precision medicine in China - Illumina
Does Illumina’s 20% Surge Signal a Reversal After GRAIL Divestiture News? - Yahoo Finance
Will Illumina Inc. (ILU) stock justify high valuationJuly 2025 Recap & Technical Buy Zone Confirmations - newser.com
Will Illumina Inc. (ILU) stock deliver stable dividends2025 Retail Activity & Safe Capital Growth Tips - newser.com
Will Illumina Inc. (ILU) stock test record highs in 2025Jobs Report & Risk Controlled Swing Alerts - newser.com
Real time pattern detection on Illumina Inc. stockRecession Risk & Daily Profit Maximizing Tips - newser.com
Why analysts maintain buy rating on Illumina Inc. (ILU) stockEarnings Beat & Risk Controlled Swing Trade Alerts - newser.com
What moving averages say about Illumina Inc.2025 Market Outlook & Smart Swing Trading Alerts - newser.com
Is Illumina Inc. (ILU) stock inflation resilient2025 Stock Rankings & AI Forecasted Stock Moves - newser.com
Transcript : Illumina, Inc. Presents at 7th Annual Wolfe Research Healthcare Conference, Nov-19-2025 09 - MarketScreener
Candlestick signals on Illumina Inc. stock todayIPO Watch & Consistent Growth Stock Picks - newser.com
Illumina at Wolfe Research Conference: Strategic Growth Amid Challenges - Investing.com India
Illumina at Wolfe Research Conference: Strategic Growth Amid Challenges By Investing.com - Investing.com Canada
3 Reasons to Sell ILMN and 1 Stock to Buy Instead - Finviz
Published on: 2025-11-19 04:40:33 - newser.com
Published on: 2025-11-18 23:37:24 - newser.com
Illumina sells GRAIL shares worth $79.85 million By Investing.com - Investing.com Australia
Illumina sells GRAIL shares worth $79.85 million - Investing.com
Tackling antimicrobial resistance, one genome at a time - Illumina
Illumina Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
Leadership Perspectives: Illumina leads the industry in genomic AI - Illumina
The Bull Case For Illumina (ILMN) Could Change Following Export Ban Easing in China—Learn Why - simplywall.st
Why Illumina Inc. stock is considered a top pickInsider Selling & Intraday High Probability Alerts - newser.com
Why The Narrative Around Illumina Is Shifting After Recent Analyst Upgrades and Sector Changes - Yahoo Finance
Demystifying MRD with BloodPac: Navigating clinical and technical pathways for comprehensive cancer monitoring - Illumina
Why Illumina Inc. (ILU) stock benefits from AI revolution2025 Earnings Surprises & Proven Capital Preservation Methods - newser.com
Is Illumina Inc. stock a buy in volatile marketsIPO Watch & Free Fast Gain Swing Trade Alerts - newser.com
Finanzdaten der Illumina Inc-Aktie (ILMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):